BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29881562)

  • 1. A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B).
    Hettiarachchi D; Nethikumara N; Pathirana BAPS; Weththasigha K; Dissanayake WDN; Dissanayake VHW
    Clin Case Rep; 2018 Jun; 6(6):1051-1054. PubMed ID: 29881562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Mutation in the NAGLU (N-Acetyl-Alpha-Glucosaminidase) Gene Associated With Mucopolysaccharidosis Type III-B in a Saudi Girl.
    Albar RF; AlQurashi RA; Naaman N; Alghamdi A; Alghamdi SK; Aljohani K; Alsharif R
    Cureus; 2022 Oct; 14(10):e30519. PubMed ID: 36415369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
    Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH
    PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of Sanfilippo syndrome type B.
    Zhao HG; Li HH; Bach G; Schmidtchen A; Neufeld EF
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6101-5. PubMed ID: 8650226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a novel homozygous deletion in the alpha-N-acetylglucosaminidase gene in a patient with Sanfilippo type B syndrome (mucopolysaccharidosis IIIB).
    Champion KJ; Basehore MJ; Wood T; Destrée A; Vannuffel P; Maystadt I
    Mol Genet Metab; 2010 May; 100(1):51-6. PubMed ID: 20138557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).
    Beesley CE; Young EP; Vellodi A; Winchester BG
    J Med Genet; 1998 Nov; 35(11):910-4. PubMed ID: 9832037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene.
    Pierzynowska K; Mański A; Limanówka M; Wierzba J; Gaffke L; Anikiej P; Węgrzyn G
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1356. PubMed ID: 32578945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.
    Chinen Y; Tohma T; Izumikawa Y; Uehara H; Ohta T
    J Hum Genet; 2005; 50(7):357-359. PubMed ID: 15933803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.
    Li HH; Yu WH; Rozengurt N; Zhao HZ; Lyons KM; Anagnostaras S; Fanselow MS; Suzuki K; Vanier MT; Neufeld EF
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14505-10. PubMed ID: 10588735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
    Aronovich EL; Johnston JM; Wang P; Giger U; Whitley CB
    Genomics; 2001 Jun; 74(3):299-305. PubMed ID: 11414757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
    Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
    Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family.
    Li J; Xie H; Jiang Y
    BMC Med Genet; 2018 Apr; 19(1):51. PubMed ID: 29606097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature.
    Meijer OLM; Te Brinke H; Ofman R; IJlst L; Wijburg FA; van Vlies N
    Mol Genet Metab; 2017 Sep; 122(1-2):100-106. PubMed ID: 28751108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAGLU mutations underlying Sanfilippo syndrome type B.
    Schmidtchen A; Greenberg D; Zhao HG; Li HH; Huang Y; Tieu P; Zhao HZ; Cheng S; Zhao Z; Whitley CB; Di Natale P; Neufeld EF
    Am J Hum Genet; 1998 Jan; 62(1):64-9. PubMed ID: 9443878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).
    Beesley CE; Jackson M; Young EP; Vellodi A; Winchester BG
    J Inherit Metab Dis; 2005; 28(5):759-67. PubMed ID: 16151907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of the α-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B.
    Birrane G; Dassier AL; Romashko A; Lundberg D; Holmes K; Cottle T; Norton AW; Zhang B; Concino MF; Meiyappan M
    J Struct Biol; 2019 Mar; 205(3):65-71. PubMed ID: 30802506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.